Angiodynamics Inc (ANGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 05/31
(Values in U.S. thousands)
| 08-2003 | 05-2003 | 05-2002 | |
| Cash Flows From Operating Activities | |||
| Net Income | 308 | 1,186 | 1,009 |
| Depreciation Amortization | 173 | 657 | 569 |
| Income taxes - deferred | N/A | 45 | 55 |
| Accounts receivable | 381 | -2,084 | -811 |
| Other Working Capital | -550 | -2,118 | -487 |
| Other Operating Activity | -154 | 2,994 | 871 |
| Operating Cash Flow | $158 | $680 | $1,206 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -354 | -4,062 | -682 |
| Purchase Of Investment | -350 | -5,847 | -8,519 |
| Sale Of Investment | 348 | 6,135 | 8,486 |
| Other Investing Activity | 75 | -798 | 0 |
| Investing Cash Flow | $-281 | $-4,572 | $-715 |
| Cash Flows From Financing Activities | |||
| Debt Issued | N/A | 3,500 | N/A |
| Debt Repayment | -35 | -105 | N/A |
| Other Financing Activity | 0 | -89 | 371 |
| Financing Cash Flow | $-35 | $3,306 | $371 |
| Beginning Cash Position | 939 | 1,525 | 663 |
| End Cash Position | 781 | 939 | 1,525 |
| Net Cash Flow | $-158 | $-586 | $862 |
| Free Cash Flow | |||
| Operating Cash Flow | 158 | 680 | 1,206 |
| Capital Expenditure | -354 | -4,062 | -682 |
| Free Cash Flow | -196 | -3,382 | 524 |